Molecular and genetic damage from environmental tobacco smoke in young children.
暂无分享,去创建一个
D. Warburton | F. Perera | S. Tannenbaum | R. Santella | D. Tang | P. Skipper | F. G. Crawford | G. S. Cereijido | Gabiela Simon Cereijido | Florence G. Crawford
[1] M. Law,et al. Environmental tobacco smoke. , 1996, British medical bulletin.
[2] P. Gergen,et al. The burden of environmental tobacco smoke exposure on the respiratory health of children 2 months through 5 years of age in the United States: Third National Health and Nutrition Examination Survey, 1988 to 1994. , 1998, Pediatrics.
[3] Nathaniel Rothman,et al. Application of Biomarkers in Cancer Epidemiology , 1997 .
[4] F P Perera,et al. Environment and cancer: who are susceptible? , 1997, Science.
[5] R. Etzel. Active and passive smoking: hazards for children. , 1997, Central European journal of public health.
[6] H. Bartsch,et al. The role of individual susceptibility in cancer burden related to environmental exposure. , 1996, Environmental health perspectives.
[7] H. Okkels,et al. Transplacental transfer of environmental genotoxins: polycyclic aromatic hydrocarbon-albumin in non-smoking women, and the effect of maternal GSTM1 genotype. , 1995, Carcinogenesis.
[8] Ş. Şardaş,et al. The effect of smoking on sister chromatid exchange rate of newborn infants born to smoking mothers. , 1995, Mutation research.
[9] S. Hecht. Environmental tobacco smoke and lung cancer: the emerging role of carcinogen biomarkers and molecular epidemiology. , 1994, Journal of the National Cancer Institute.
[10] F. Perera,et al. Biomarkers of environmental tobacco smoke in preschool children and their mothers. , 1994, Journal of the National Cancer Institute.
[11] J. Little,et al. Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence. , 1994, Paediatric and perinatal epidemiology.
[12] B. Henderson,et al. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. , 1994, Journal of the National Cancer Institute.
[13] S. Tannenbaum,et al. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. , 1993, Journal of the National Cancer Institute.
[14] V. Chen. Smoking and the health gap in minorities. , 1993, Annals of epidemiology.
[15] E. Feuer. Stat Bite. Impact of combination chemotherapy for advanced testicular cancer. , 1992, Journal of the National Cancer Institute.
[16] S. Tannenbaum,et al. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero. , 1991, Journal of the National Cancer Institute.
[17] M. Melamed,et al. Lung cancer and exposure to tobacco smoke in the household. , 1990, The New England journal of medicine.
[18] S. Tannenbaum,et al. Protein adducts in the molecular dosimetry of chemical carcinogens. , 1990, Carcinogenesis.
[19] H. Järventaus,et al. Cytogenetic effects of tobacco smoke exposure among involuntary smokers. , 1989, Mutation research.
[20] R. Santella,et al. Quantitation of protein adducts as a marker of genotoxic exposure: immunologic detection of benzo[a]pyrene--globin adducts in mice. , 1988, Carcinogenesis.
[21] F. Perera,et al. Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA. , 1988, Carcinogenesis.
[22] A. Carrano. Chromosomal alterations as markers of exposure and effect. , 1986, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[23] N. Haley,et al. Elimination from the body of tobacco products by smokers and passive smokers. , 1986, JAMA.
[24] R. Davis,et al. The determination of nicotine and cotinine in plasma. , 1986, Journal of chromatographic science.
[25] I. Weinstein,et al. Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide. , 1984, Carcinogenesis.
[26] R. L. Carter,et al. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.
[27] S. Wolff,et al. New Giemsa method for the differential staining of sister chromatids , 1974, Nature.
[28] J D Tucker,et al. Cytogenetic end-points as biological dosimeters and predictors of risk in epidemiological studies. , 1997, IARC scientific publications.
[29] P. Skipper,et al. Aromatic amine-hemoglobin adducts. , 1994, Methods in enzymology.
[30] Children. Pesticides in the Diets of Infants and Children , 1993 .
[31] G. Burke,et al. Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. , 1992, American journal of public health.
[32] F. Perera. Molecular cancer epidemiology: a new tool in cancer prevention. , 1987, Journal of the National Cancer Institute.
[33] Education . Office on Smoking,et al. The health consequences of involuntary smoking : a report of the Surgeon General , 1986 .
[34] S. Colowick,et al. Methods in Enzymology , Vol , 1966 .